Changes of TXA2 and PGI2 during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage

Zhi Wang , Chao Wang , Weiguang Zhang , Laizang Wang , Ting Lei

Current Medical Science ›› 2008, Vol. 28 ›› Issue (22) : 87 -89.

PDF
Current Medical Science ›› 2008, Vol. 28 ›› Issue (22) : 87 -89. DOI: 10.1007/s11596-008-0122-9
Article

Changes of TXA2 and PGI2 during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage

Author information +
History +
PDF

Abstract

In order to explore the changes and the roles of TXA2 and PGI2 during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage, 31 cases subject to craniotomy were divided into three groups: group A, 9 patients with postoperative hypertensive crisis; group B, 13 patients without postoperative hypertensive crisis; and group C, 9 patients without history of hypertension and hypertensive intracerebral hemorrhage. TXA2, TXB2, 6-keto-PGF1α and PGI2 were measured after operation in the three groups respectively. The postoperative blood pressure in group A, including SBP and DBP, was elevated more obviously than that in the other two groups. TXA2 and PGI2 in group A were significantly higher than those in other two groups (P<0.01). Moreover, the ratio of TXB2 to 6-keto-PGF1α in group A was significantly higher than that in other two groups (P<0.05). The increase of TXA2 and the relative inadequacy of prostacyclin, especially 6-keto-PGF1α, may play roles in the postoperative hypertensive crisis. And the increased value of TXB2 to 6-keto-PGF1α could provide the basis for diagnosis of postoperative hypertensive crisis.

Keywords

hypertensive intracerebral hemorrhage / hypertensive crisis / TXA2 / PGI2

Cite this article

Download citation ▾
Zhi Wang, Chao Wang, Weiguang Zhang, Laizang Wang, Ting Lei. Changes of TXA2 and PGI2 during postoperative hypertensive crisis in patients with hypertensive intracerebral hemorrhage. Current Medical Science, 2008, 28(22): 87-89 DOI:10.1007/s11596-008-0122-9

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

PatelH. P., MitsnefesM.. Advances in the pathogenesis and management of hypertensive crisis. Curr Opin Pediatr, 2005, 17: 210-214

[2]

TuncelM., RamV. C.. Hypertensive emergencies. Etiology and management. Am J Cardiovasc Drugs, 2003, 3: 21-31

[3]

MarikP. E., VaronJ.. Hypertensive crises: challenges and management. Chest, 2007, 131(6): 1949-1962

[4]

JosephV., PaulE. M.. The diagnosis and management of hypertensive crises. Chest, 2000, 118: 214-227

[5]

BlumenfeldJ. D., LaraghJ. H.. Management of hypertensive crises: the scientific basis for treatment decisions. Am J Hypertens, 2001, 14: 1154-1167

[6]

MartinJ. F., HigashiamaE., GarciaE., et al.. Hypertensive Crisis Profile: Prevalence and Clinical Presentation. Arquivos Brasileiros de Cardiologia, 2004, 83: 131-136

[7]

RosenowD. J., RussellE.. Current concepts in the management of hypertensive crisis: emergencies and urgencies. Holist Nurs Pract, 2001, 15: 12-21

[8]

RuanK. H., DengH., SoS. P.. Engineering of a protein with cyclooxygenase and prostacyclin synthase activities that converts arachidonic acid to prostacyclin. Biochemistry, 2006, 45(47): 14003-14011

AI Summary AI Mindmap
PDF

84

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/